Publikationen 2018

  1. Bahri R, Custovic A, Korosec P, Tsoumani M, Barron M, Wu J, Sayers R, Weimann A, Ruiz-Garcia M, Patel N, Robb A, Shamji MH, Fontanella S, Silar M, Mills ENC, Simpson A, Turner PJ, Bulfone-Paus S. Mast cell activation test in the diagnosis of allergic disease and anaphylaxis. J Allergy Clin Immunol doi: 10.1016/j.jaci.2018.01.043 [Epub] (2018).
  2. Blankestijn MA, Otten HG, Suer W, Weimann A, Knol EF, Knulst AC. Specific IgE to peanut 2S albumin Ara  h 7 has a discriminative ability comparable to Ara h 2 and 6. Clin Exp Allergy 48(1):65-65 (2018).
  3. Bremer HD, Landegren N, Sjöberg R, Hallgren A, Renneker S, Lattwein E, Leonard D, Eloranta ML, Rönnblom L, Nordmark G, Nilsson P, Andersson G, Liliehöök I, Lindblad-Toh K, Kämpe O, Hansson-Hamlin H. ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease. Sci Pep 8(1):4852 (2018).
  4. Carter JB, Carter S, Saschenbrecker S, Goeckeritz BE. Recognition and relevance of anti-DFS70 autoantibodies in routine antinuclear autoantibodies testing at a community hospital. Front Med 5:88 (2018).
  5. Gille B, Dedeene L, Stoops E, Demeyer L, Francois C, Lefever S, De Schaepdryver M, Brix B, Vandenberghe R, Tournoy J, Vanderstichele H, Poesen K. Automation on an open-access platform of Alzheimer’s disease biomarker immunoassays. SLAS Technol doi: 10.1177/2472630317750378. [Epub] (2018).
  6. Hayen SM, Ehlers AM, den Hartog Jager CF, Garssen J, Knol EF, Knulst EF, Suer W, Willemsen LEM, Otten HG. 2S protein Ara h 7.0201 has unique epitopes compared to other Ara h 7 isoforms and is comparable to 2S proteins Ara h 2 and 6 in basophil degranulation capacity. Clin Exp Allergy doi: 10.1111/cea.13134 [Epub] (2018).
  7. Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M, Abdelhak A, Grüter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F, Wildemann B. MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature. J Neuroinflammation 15(1):88 (2018).
  8. Kovacs G, Sipeki N, Suga B, Tornai T, Fechner K, Norman GL, Shums Z, Antal-Szalmas P, Papp M. Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients. PLoS One 13(3):e0194166 (2018).
  9. Lütt A, Michel K, Krüger D, Volz MS, Nassir M, Schulz E, Poralla L, Tangermann P, Bojarski C, Höltje M, Teegen B, Stöcker W, Schemann M, Siegmund B, Prüss H. High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders. Neurogastroenterol Motil doi: 10.1111/nmo.13292 [Epub] (2018).
  10. Neumann K, Cavalar M, Rody A, Friemert L, Beyer DA. Is surgical plume developing during routine LEEPs contaminted with high-risk HPV? A pilot series of experiments. Arch Gynecol Obstet 297(2):421-424 (2018).
  11. Pan H, Oliveira B, Saher G, Dere E, Tapken D, Mitjans M, Seidel J, Wesolowski J, Wakhloo D, Klein-Schmidt C, Ronnenberg A, Schwabe A, Trippe R, Mätz-Rensing K, Berghoff S, Al-Krinawe Y, Martens H, Begemann M, Stöcker W, Kaup FJ, Mischke R, Boretius S, Nave KA, Krauss JK, Hollmann M, Lühder F, Ehrenreich H. Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model. Mol Psychiatry doi: 10.1038/s41380-017-0011-3 [Epub] (2018).
  12. Perez-Riverol A, Fernandes LGR, Musacchio Lasa A, Dos Santos-Pinto JRA, Moitinho Abram D, Izuka Moraes GH, Jabs F, Miehe M, Seismann H, Palma MS, de Lima Zollner R, Spillner E, Brochetto-Braga MR. Phospholipase A1-based cross-reactivity among venoms of clinically relevant Hymenoptera from neotropical and temperate regions. Mol Immunol 93:87-93 (2018).
  13. Scherberich J, Gruber R, Nockher WA, Christensen EI, Schmitt H, Herbst V, Block M, Kaden J, Schlumberger W. Serum uromodulin – a marker of kidney function and renal parenchymal integrity. Nephrol Dial Transplant 33(2):284-295 (2018).
  14. Tornai T, Tornai D, Sipeki N, Tornai I, Alsulaimani R, Fechner K, Roggenbuck D, Norman GL, Veres G, Par G, Par A, Szalay F, Lakatos PL, Antal-Szalmas P, Papp M. Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis. Sci Rep 8(1):399 (2018).